Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announces that it is now shipping cannulas along with its syringes of its LACRIFILL® Canalicular Gel, a novel therapy for dry eye symptoms. The company made the decision to enhance its offering in response to feedback from doctors, and the provided cannulas have been very well received.

Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announces that it is now shipping cannulas along with its syringes of its LACRIFILL® Canalicular Gel, a novel therapy for dry eye symptoms. The company made the decision to enhance its offering in response to feedback from doctors, and the provided cannulas have been very well received.